In a phase I study including 25 patients with relapsed or refractory T-ALL or T cell lymphoblastic lymphoma, eight patients showed a more than 50% reduction in their bone marrow blast counts with responses occurring in both NOTCH1-mutant and NOTCH1-wild-type subgroups. Here, NOTCH1 is linked to acute lymphoblastic leukemia.